Page last updated: 2024-08-18

4-butyrolactone and thromboplastin

4-butyrolactone has been researched along with thromboplastin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kottke-Marchant, K; Marchant, RE; Murugesan, G; Rani, MR; Ransohoff, RM1
Dai, J; Huang, J; Jiang, R; Tang, L; Tian, R; Yang, Y; Zhang, L1

Other Studies

2 other study(ies) available for 4-butyrolactone and thromboplastin

ArticleYear
Endothelial cell expression of monocyte chemotactic protein-1, tissue factor, and thrombomodulin on hydrophilic plasma polymers.
    Journal of biomedical materials research, 2000, Mar-05, Volume: 49, Issue:3

    Topics: 4-Butyrolactone; Base Sequence; Biocompatible Materials; Cells, Cultured; Chemokine CCL2; DNA Primers; Endothelium, Vascular; Gene Expression; Humans; Materials Testing; Povidone; RNA, Messenger; Surface Properties; Thrombomodulin; Thromboplastin; Tumor Necrosis Factor-alpha

2000
The SIRT1 inhibitor EX-527 suppresses mTOR activation and alleviates acute lung injury in mice with endotoxiemia.
    Innate immunity, 2017, Volume: 23, Issue:8

    Topics: 4-Butyrolactone; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Animals; Carbazoles; Carrier Proteins; Cell Cycle Proteins; Endotoxemia; Eukaryotic Initiation Factors; Interleukin-6; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Phosphoproteins; Phosphorylation; Plasminogen Activator Inhibitor 1; Sirtuin 1; Thromboplastin; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha

2017